BAYRY:OTC-Bayer Aktiengesellschaft (USD)

COMMON STOCK | Drug Manufacturers-General | OTC

Last Closing Price

USD 15.82

Change

0.00 (0.00)%

Market Cap

USD 62.37B

Volume

0.26M

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University, Sensyne Health plc, and Atomwise Inc. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-01-17 )

Largest Industry Peers for Drug Manufacturers-General

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RHHVF Roche Holding AG

N/A

USD305.89B 28.62 14.52
RHHBF Roche Holding AG

N/A

USD305.89B 29.25 14.52
RHHBY Roche Holding AG

N/A

USD305.89B 21.54 14.52
NVSEF Novartis AG

N/A

USD218.40B 31.07 14.33
AZNCF AstraZeneca PLC

N/A

USD136.35B 54.63 18.12
SNYNF Sanofi

N/A

USD124.45B 25.41 7.41
GLAXF GlaxoSmithKline plc

N/A

USD97.28B 39.25 14.96
CHGCY Chugai Pharmaceutical Co., Ltd

N/A

USD93.23B 9.91 0.31
CHGCF Chugai Pharmaceutical Co., Ltd

N/A

USD87.58B 41.79 0.31
DSNKY Daiichi Sankyo Company, Limite..

N/A

USD68.42B 36.40 0.34

ETFs Containing BAYRY

Symbol Name Weight Mer Price(Change) Market Cap
EWG iShares MSCI Germany ETF 0.00 % 0.49 %

N/A

USD2.58B
C001:XETRA Lyxor Core DAX (DR) UCITS.. 0.00 % 0.08 %

N/A

USD1.02B
WTDH:F WisdomTree Europe Equity .. 0.00 % 0.58 %

N/A

N/A
WTEE:F WisdomTree Europe Equity .. 0.00 % 0.29 %

N/A

USD0.02B
WTEZ:F WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

N/A
XDDX:F Xtrackers DAX Income UCIT.. 0.00 % 0.09 %

N/A

N/A
ZPRE:F SPDR MSCI EMU UCITS ETF 0.00 % 0.18 %

N/A

USD0.21B
AMED:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
C002:XETRA ComStage - FR DAX UCITS E.. 0.00 % 0.15 %

N/A

USD0.05B
VX5E:F Vanguard Euro STOXX 50 UC.. 0.00 % 0.00 %

N/A

USD0.04B
C003:XETRA Lyxor DivDAX (DR) UCITS E.. 0.00 % 0.25 %

N/A

USD0.07B
C006:XETRA Lyxor F.A.Z. 100 Index (D.. 0.00 % 0.15 %

N/A

USD0.08B
C068:XETRA ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.08B
CEBP:XETRA iShares VII PLC - iShares.. 0.00 % 0.38 %

N/A

USD0.19B
CEMS:XETRA iShares Edge MSCI Europe .. 0.00 % 0.25 %

N/A

USD1.59B
CEUG:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD2.32B
WTDF:F WisdomTree Europe Equity .. 0.00 % 0.32 %

N/A

N/A
UIME:F UBS ETF - MSCI EMU Value .. 0.00 % 0.25 %

N/A

USD0.15B
DBPD:XETRA Xtrackers ShortDAX x2 Dai.. 0.00 % 0.60 %

N/A

USD0.12B
IS3G:F iShares MSCI EMU Large Ca.. 0.00 % 0.49 %

N/A

USD0.08B
EL4F:F Deka DAX (ausschÃ.. 0.00 % 0.15 %

N/A

USD0.79B
ELF0:F Deka DAX ex Financials 30.. 0.00 % 0.30 %

N/A

USD0.03B
EMUX:F BNP Paribas Easy MSCI EMU.. 0.00 % 0.00 %

N/A

USD0.25B
EXSB:F iShares DivDAX UCITS ETF .. 0.00 % 0.31 %

N/A

USD0.45B
EXV4:F iShares STOXX Europe 600 .. 0.00 % 0.46 %

N/A

USD0.64B
IQQV:F iShares Euro Total Market.. 0.00 % 0.40 %

N/A

USD0.03B
IUSR:F iShares EURO STOXX 50 ex-.. 0.00 % 0.10 %

N/A

USD0.04B
UIM4:F UBS ETF - MSCI EMU UCITS .. 0.00 % 0.18 %

N/A

N/A
LGWS:F Lyxor Index Fund - Lyxor .. 0.00 % 0.40 %

N/A

USD0.34B
LMVF:F Lyxor MSCI EMU (DR) UCITS.. 0.00 % 0.25 %

N/A

USD0.24B
LYSX:F Lyxor Euro Stoxx 50 (DR) .. 0.00 % 0.20 %

N/A

N/A
LYY7:F MULTI-UNITS LUXEMBOURG - .. 0.00 % 0.15 %

N/A

USD0.78B
SPYH:F SPDR MSCI Europe Health C.. 0.00 % 0.30 %

N/A

USD0.41B
SPYW:F SPDR S&P Euro Dividend Ar.. 0.00 % 0.30 %

N/A

USD1.20B
SXR7:F iShares VII PLC -iShares .. 0.00 % 0.12 %

N/A

N/A
D5BL:XETRA Xtrackers MSCI Europe Val.. 0.00 % 0.25 %

N/A

USD9.16M
DBXD:XETRA Xtrackers DAX UCITS ETF 1.. 0.00 % 0.09 %

N/A

USD3.69B
E903:F Lyxor 1 DivDAX UCITS ETF .. 0.00 % 0.25 %

N/A

USD0.03B
VX5E:XETRA Vanguard Euro STOXX 50 UC.. 0.00 % 0.00 %

N/A

USD0.04B
SPYW:XETRA SPDR S&P Euro Dividend Ar.. 0.00 % 0.30 %

N/A

USD1.26B
SXR7:XETRA iShares VII PLC -iShares .. 0.00 % 0.12 %

N/A

N/A
UIM4:XETRA UBS ETF - MSCI EMU UCITS .. 0.00 % 0.18 %

N/A

N/A
UIME:XETRA UBS ETF - MSCI EMU Value .. 0.00 % 0.25 %

N/A

USD0.15B
V50A:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
VDXX:XETRA Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

USD0.04B
WTDF:XETRA WisdomTree Europe Equity .. 0.00 % 0.32 %

N/A

N/A
LYY7:XETRA MULTI-UNITS LUXEMBOURG - .. 0.00 % 0.15 %

N/A

USD0.60B
WTDH:XETRA WisdomTree Europe Equity .. 0.00 % 0.58 %

N/A

N/A
WTEE:XETRA WisdomTree Europe Equity .. 0.00 % 0.29 %

N/A

USD0.02B
WTEZ:XETRA WisdomTree Germany Equity.. 0.00 % 0.32 %

N/A

N/A
X503:XETRA ComStage - iBOXX Euro Liq.. 0.00 % 0.12 %

N/A

USD5.98M
XD5E:XETRA Xtrackers MSCI EMU UCITS .. 0.00 % 0.12 %

N/A

N/A
XDDX:XETRA Xtrackers DAX Income UCIT.. 0.00 % 0.09 %

N/A

N/A
EXS1:XETRA iShares Core DAX UCITS ET.. 0.00 % 0.16 %

N/A

USD6.40B
SPYH:XETRA SPDR MSCI Europe Health C.. 0.00 % 0.30 %

N/A

USD0.41B
LYSX:XETRA Lyxor Euro Stoxx 50 (DR) .. 0.00 % 0.20 %

N/A

N/A
DXSA:XETRA Xtrackers Euro Stoxx Qual.. 0.00 % 0.30 %

N/A

USD0.20B
EMUX:XETRA BNP Paribas Easy MSCI EMU.. 0.00 % 0.00 %

N/A

USD0.25B
E901:XETRA Lyxor 1 DAX UCITS ETF (I) 0.00 % 0.15 %

N/A

USD0.10B
E903:XETRA Lyxor 1 DivDAX UCITS ETF .. 0.00 % 0.25 %

N/A

USD0.04B
EESM:XETRA BNP Paribas Easy MSCI Eur.. 0.00 % 0.00 %

N/A

USD0.09B
EL4A:XETRA Deka DAX UCITS ETF 0.00 % 0.00 %

N/A

USD1.05B
EL4F:XETRA Deka DAX (ausschÃ.. 0.00 % 0.15 %

N/A

USD0.86B
ELF0:XETRA Deka DAX ex Financials 30.. 0.00 % 0.30 %

N/A

USD0.02B
EXSB:XETRA iShares DivDAX UCITS ETF .. 0.00 % 0.31 %

N/A

USD0.49B
LMVF:XETRA Lyxor MSCI EMU (DR) UCITS.. 0.00 % 0.25 %

N/A

USD0.24B
EXV4:XETRA iShares STOXX Europe 600 .. 0.00 % 0.46 %

N/A

USD0.65B
FRCA:XETRA UBS ETF - MSCI EMU hedged.. 0.00 % 0.28 %

N/A

USD0.35B
GOAI:XETRA Amundi Stoxx Global Artif.. 0.00 % 0.00 %

N/A

USD0.19B
IQQV:XETRA iShares Euro Total Market.. 0.00 % 0.40 %

N/A

USD0.03B
IS3G:XETRA iShares MSCI EMU Large Ca.. 0.00 % 0.49 %

N/A

USD0.09B
IUSR:XETRA iShares EURO STOXX 50 ex-.. 0.00 % 0.10 %

N/A

USD0.04B
LGWS:XETRA Lyxor Index Fund - Lyxor .. 0.00 % 0.40 %

N/A

USD0.34B
EL4A:F Deka DAX UCITS ETF 0.00 % 0.00 %

N/A

USD1.00B
E901:F Lyxor 1 DAX UCITS ETF (I) 0.00 % 0.15 %

N/A

USD0.10B
HEWG iShares Currency Hedged M.. 0.00 % 0.53 %

N/A

USD0.06B
HEDK:LSE WisdomTree Europe Equity .. 0.00 % 0.58 %

N/A

N/A
EEIP:LSE WisdomTree Europe Equity .. 0.00 % 0.29 %

N/A

USD0.02B
EMUU:LSE iShares VII PLC - iShares.. 0.00 % 0.38 %

N/A

USD0.19B
EUDV:LSE SPDR S&P Euro Dividen.. 0.00 % 0.30 %

N/A

USD1.26B
HEDF:LSE WisdomTree Europe Equity .. 0.00 % 0.32 %

N/A

N/A
HEDG:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

N/A
HEDJ:LSE WisdomTree Europe Equity .. 0.00 % 0.58 %

N/A

N/A
HEDP:LSE WisdomTree Europe Equity .. 0.00 % 0.35 %

N/A

N/A
EEI:LSE WisdomTree Europe Equity .. 0.00 % 0.29 %

N/A

USD0.02B
HEDS:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.58 %

N/A

N/A
HLTH:LSE SPDR MSCI Europe Health C.. 0.00 % 0.30 %

N/A

USD0.41B
IDJV:LSE iShares Euro Total Market.. 0.00 % 0.40 %

N/A

USD0.03B
IEDL:LSE iShares Edge MSCI Europe .. 0.00 % 0.25 %

N/A

USD1.59B
IEFV:LSE iShares Edge MSCI Europe .. 0.00 % 0.25 %

N/A

USD0.84B
IEVL:LSE iShares Edge MSCI Europe .. 0.00 % 0.25 %

N/A

USD1.59B
EEIE:LSE WisdomTree Europe Equity .. 0.00 % 0.29 %

N/A

USD0.02B
DXGZ:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

N/A
EMUE:LSE SPDR MSCI EMU UCITS ETF 0.00 % 0.18 %

N/A

USD0.29B
EHE-B:CA CI WisdomTree Europe Hedg.. 0.00 % 0.58 %

N/A

N/A
HEZU iShares Currency Hedged M.. 0.00 % 0.52 %

N/A

USD0.50B
IVLU iShares Edge MSCI Intl Va.. 0.00 % 0.30 %

N/A

USD0.57B
ZDI:CA BMO International Dividen.. 0.00 % 0.40 %

N/A

USD0.36B
EHE:CA CI WisdomTree Europe Hedg.. 0.00 % 0.66 %

N/A

USD0.03B
MINT:CA Manulife Multifactor Deve.. 0.00 % 0.62 %

N/A

USD0.57B
ZVI:CA BMO MSCI EAFE Value Index.. 0.00 % 0.40 %

N/A

USD3.93M
CEU1:LSE iShares VII PLC -iShares .. 0.00 % 0.12 %

N/A

N/A
DXGY:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

N/A
CEUG:LSE iShares VII PLC -iShares .. 0.00 % 0.12 %

N/A

N/A
CEUR:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD2.33B
CMU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
DAXX:LSE MULTI-UNITS LUXEMBOURG - .. 0.00 % 0.15 %

N/A

USD0.84B
DXGE:LSE WisdomTree Germany Equity.. 0.00 % 0.48 %

N/A

N/A
DXGG:LSE WisdomTree Germany Equity.. 0.00 % 0.48 %

N/A

N/A
DXGP:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.35 %

N/A

N/A
MSEU:LSE Lyxor Euro Stoxx 50 (DR) .. 0.00 % 0.20 %

N/A

N/A
UB06:LSE UBS ETF - MSCI EMU UCITS .. 0.00 % 0.18 %

N/A

N/A
DXSA:F Xtrackers Euro Stoxx Qual.. 0.00 % 0.30 %

N/A

USD0.16B
C002:F ComStage FR DAX UCITS ETF 0.00 % 0.15 %

N/A

USD0.05B
MFE:PA Lyxor MSCI EMU (DR) UCITS.. 0.00 % 0.25 %

N/A

USD0.24B
MSE:PA Lyxor Euro Stoxx 50 (DR) .. 0.00 % 0.20 %

N/A

N/A
MFED:PA Lyxor EURO STOXX 300 (DR).. 0.00 % 0.07 %

N/A

USD0.39B
STW:PA SPDR MSCI Europe Health C.. 0.00 % 0.30 %

N/A

USD0.41B
VAL:PA Lyxor Index Fund - Lyxor .. 0.00 % 0.40 %

N/A

USD0.34B
C001:F ComStage DAX UCITS ETF 0.00 % 0.08 %

N/A

USD0.87B
C003:F ComStage DivDAX UCITS ETF 0.00 % 0.25 %

N/A

USD0.06B
EUDV:PA SPDR S&P Euro Dividend Ar.. 0.00 % 0.30 %

N/A

USD1.26B
C006:F ComStage - F.A.Z. Index U.. 0.00 % 0.15 %

N/A

USD0.08B
C068:F ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.08B
CEBP:F iShares VII PLC - iShares.. 0.00 % 0.38 %

N/A

USD0.19B
CEMS:F iShares Edge MSCI Europe .. 0.00 % 0.25 %

N/A

USD1.59B
D5BL:F Xtrackers MSCI Europe Val.. 0.00 % 0.25 %

N/A

USD7.86M
DBPD:F Xtrackers ShortDAX x2 Dai.. 0.00 % 0.60 %

N/A

USD0.18B
DBXD:F Xtrackers DAX UCITS ETF 1.. 0.00 % 0.09 %

N/A

USD3.54B
MFDD:PA Lyxor EURO STOXX 300 (DR).. 0.00 % 0.07 %

N/A

USD0.39B
EMUE:PA SPDR MSCI EMU UCITS ETF 0.00 % 0.18 %

N/A

USD0.29B
UB17:LSE UBS ETF - MSCI EMU Value .. 0.00 % 0.25 %

N/A

USD0.15B
XDDX:LSE Xtrackers DAX Income UCIT.. 0.00 % 0.09 %

N/A

N/A
UC89:LSE UBS ETF - MSCI EMU hedged.. 0.00 % 0.28 %

N/A

USD0.35B
XD3E:LSE Xtrackers Euro Stoxx Qual.. 0.00 % 0.30 %

N/A

USD0.20B
XD5D:LSE Xtrackers MSCI EMU UCITS .. 0.00 % 0.17 %

N/A

N/A
XD5E:LSE Xtrackers MSCI EMU UCITS .. 0.00 % 0.12 %

N/A

N/A
XD5S:LSE Xtrackers MSCI EMU UCITS .. 0.00 % 0.17 %

N/A

N/A
XDAX:LSE Xtrackers DAX UCITS ETF 1.. 0.00 % 0.09 %

N/A

USD3.69B
XSD2:LSE Xtrackers ShortDAX x2 Dai.. 0.00 % 0.60 %

N/A

USD0.12B
EESM:PA BNP Paribas Easy MSCI Eur.. 0.00 % 0.00 %

N/A

USD0.09B
VDXX:LSE Vanguard Germany All Cap .. 0.00 % 0.00 %

N/A

USD0.04B
VX5E:LSE Vanguard Euro STOXX 50 UC.. 0.00 % 0.00 %

N/A

USD0.04B
XSSX:LSE Xtrackers Euro Stoxx 50 S.. 0.00 % 0.40 %

N/A

USD0.14B
C50:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
CMU:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
DAX:PA MULTI-UNITS LUXEMBOURG - .. 0.00 % 0.15 %

N/A

USD0.84B
EEMU:PA BNP Paribas Easy MSCI EMU.. 0.00 % 0.00 %

N/A

USD0.25B
1387:TSE UBS ETF - MSCI EMU UCITS .. 0.00 % 0.18 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-General)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.60% 79% C+ 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.60% 79% C+ 55% F
Trailing 12 Months  
Capital Gain -24.45% 14% F 23% F
Dividend Return 3.67% 87% B+ 70% C-
Total Return -20.78% 14% F 25% F
Trailing 5 Years  
Capital Gain -42.91% 20% F 24% F
Dividend Return 12.14% 77% C+ 41% F
Total Return -30.77% 20% F 28% F
Average Annual (5 Year Horizon)  
Capital Gain -7.94% 20% F 24% F
Dividend Return 2.84% 63% D 60% D-
Total Return -5.10% 20% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 24.50% 46% F 66% D
Risk Adjusted Return -20.80% 20% F 28% F
Market Capitalization 62.37B 71% C- 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-General)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 8.58 100% A+ 70% C-
Price/Book Ratio 1.65 74% C 50% F
Price / Cash Flow Ratio 7.60 49% F 22% F
EV/EBITDA 10.06 52% F 34% F
Management Effectiveness  
Return on Equity -41.12% 6% F 20% F
Return on Invested Capital 4.77% 29% F 54% F
Return on Assets -7.35% 9% F 36% F
Debt to Equity Ratio 75.96% 25% F 26% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.34 6% F 33% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector